The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies

Archives of Neurology

Volumn 57, Issue 11, 2000, Pages 1596-1600

  Romi, F ^a   Skeie, G O ^a   Aarli, J A ^a   Gilhus, N E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; RYANODINE RECEPTOR;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROGNOSIS; THYMECTOMY; THYMOMA;

EID: 0033751724     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.11.1596     Document Type: Article

References (38)

1. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value
2. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome
3. Modulation of acetylcholine receptor function in TE671 cells by non-AChR ligands: Possible relevance to seronegative myasthenia gravis
4. Anti-acetylcholine receptor antibodies in myasthenia gravis, II: Clinical and serological follow-up of individual patients
5. CA-antibody: An immunological marker of thymic neoplasia in myasthenia gravis?
6. Studies on autoantibodies in myasthenia gravis
7. Human monoclonal striational autoantibodies isolated from thymic B lymphocytes of patients with myasthenia gravis use VH and VL gene segments associated with the autoimmune repertoire
8. Non-receptor striated muscle antibodies in sera from patients with myasthenia gravis
9. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin
10. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmatic reticulum
11. Muscle autoantibodies in subgroups of myasthenia gravis patients
12. Paraneoplastic myasthenia gravis: Detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor
13. Titin antibodies in patients with late onset myasthenia gravis: Clinical correlations
14. Ryanodine receptor antibodies are associated with severe myasthenia gravis
15. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis
16. Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients
17. Antibodies to skeletal muscle in myasthenia gravis, II: Prevalence in non-thymoma patients
18. Clinical heterogeneity of seronegative MG
19. One hundred consecutive thymectomies for myasthenia gravis
20. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis
21. Myasthenia gravis activities of daily living profile
22. Determination of acetylcholine receptor antibody in myasthenia gravis: Clinical usefulness and pathogenic implications
23. Myasthenia gravis: Difference between thymo ma-associated antibodies and cross-striational skeletal muscle antibodies
24. Ryanodine receptor autoantibodies in myasthenia gravis patients with thymoma
25. Antibodies to skeletal muscle in myasthenia gravis, III: Relation with clinical course and therapy
26. Observations of the natural history of myasthenia gravis and the effect of thymectomy
27. The long-term clinical outcome of myasthenia gravis in patients with thymoma
28. Late-onset myasthenia gravis
29. Epidemiologic evidence for a changing natural history of myasthenia gravis
30. Titin transcripts in thymoma
31. Ryanodine receptor gene expression in thymomas
32. The pathological basis of thymoma-associated myasthenia gravis
33. Pathogenesis of myasthenia gravis: Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors
34. Analysis of the acetylcholine receptor epitope-bearing protein p153 in thymomas favours 'false-positive T-cell selection' as a mechanism of paraneoplastic myasthenia gravis
35. A striational muscle antigen and myasthenia gravis-associated thymomas share an acetylcholine-receptor epitope
36. Early-onset myasthenia gravis: A recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a
37. Inflammatory myopathy in myasthenia gravis
38. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis